On September 15, 2023, Dr. Vijay Modur, Head of Research and Development of Eloxx Pharmaceuticals, Inc., notified the Company of his resignation effective September 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8058 USD | +2.65% | +0.60% | -32.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.85% | 2.66M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ELOX Stock
- News Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals, Inc. Announces Resignation of Vijay Modur as Head of Research and Development